Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila Kansiime

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Plos One|August 10, 2019
Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, UgandaSheila Kansiime, Doris Mwesigire, Henry Mugerwa
Tropical Medicine & International Health : TM & IH|July 27, 2023
Developing HIV risk prediction tools in four African settingsSheila Kansiime, Christian Holm Hansen, Richard Hayes, et al.
International Journal of Environmental Research and Public Health|June 10, 2022
Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, UgandaAnita Kabarambi, Sheila Kansiime, Sylvia Kusemererwa, et al.
Clinical Trials (London, England)|January 23, 2025
Challenges in estimating the counterfactual placebo HIV incidence rate from a registration cohort: The PrEPVacc trialSheila Kansiime, Christian Holm Hansen, Eugene Ruzagira, et al.
Reproductive Health|December 28, 2024
Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective secondary analysisSylvia Kusemererwa, Sheila Kansiime, Sarah Nakamanya, et al.
Statistical Communications in Infectious Diseases|January 22, 2024
Study design approaches for future active-controlled HIV prevention trialsDeborah Donnell, Sheila Kansiime, David V Glidden, et al.
HIV Research & Clinical Practice|June 11, 2025
Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo armSheila Kansiime, Christian Holm Hansen, Henry Bern, et al.
Global Health Action|August 7, 2023
Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, UgandaJonathan Kitonsa, Sheila Kansiime, Sylvia Kusemererwa, et al.
Medicine|December 6, 2021
Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, UgandaSylvia Kusemererwa, Sheila Kansiime, Gertrude Mutonyi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Nocturnal systolic blood pressure dipping among people living with HIV and people without HIV: a cross-sectional study in Rural UgandaIsaac Sekitoleko, Sheila Kansiime, Viola Mugamba, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|August 10, 2019
Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, UgandaSheila Kansiime, Doris Mwesigire, Henry Mugerwa
Tropical Medicine & International Health : TM & IH|July 27, 2023
Developing HIV risk prediction tools in four African settingsSheila Kansiime, Christian Holm Hansen, Richard Hayes, et al.
International Journal of Environmental Research and Public Health|June 10, 2022
Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, UgandaAnita Kabarambi, Sheila Kansiime, Sylvia Kusemererwa, et al.
Clinical Trials (London, England)|January 23, 2025
Challenges in estimating the counterfactual placebo HIV incidence rate from a registration cohort: The PrEPVacc trialSheila Kansiime, Christian Holm Hansen, Eugene Ruzagira, et al.
Reproductive Health|December 28, 2024
Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective secondary analysisSylvia Kusemererwa, Sheila Kansiime, Sarah Nakamanya, et al.
Statistical Communications in Infectious Diseases|January 22, 2024
Study design approaches for future active-controlled HIV prevention trialsDeborah Donnell, Sheila Kansiime, David V Glidden, et al.
HIV Research & Clinical Practice|June 11, 2025
Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo armSheila Kansiime, Christian Holm Hansen, Henry Bern, et al.
Global Health Action|August 7, 2023
Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, UgandaJonathan Kitonsa, Sheila Kansiime, Sylvia Kusemererwa, et al.
Medicine|December 6, 2021
Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, UgandaSylvia Kusemererwa, Sheila Kansiime, Gertrude Mutonyi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Nocturnal systolic blood pressure dipping among people living with HIV and people without HIV: a cross-sectional study in Rural UgandaIsaac Sekitoleko, Sheila Kansiime, Viola Mugamba, et al.
Pageof 2